Skip to main content

Table 1 Patient characteristics

From: Point of care aspergillus testing in intensive care patients

  Case Control p
n 55 123  
Center = Rotterdam (%) 22 (40.0) 54 (43.9) 0.747
Age, years (median [IQR]) 63 [56, 68] 57 [46, 66] 0.073
Male gender (%) 34 (61.8) 66 (53.7) 0.395
Weight, kg (median [IQR]) 70 [60, 84] 70 [62, 85] 0.910
Underlying disease (%)    0.355
Pulmonary disease 22 (40.0) 59 (52.2)  
Hematologic malignancy 9 (16.4) 10 (8.8)  
Heart disease 4 (7.3) 10 (8.8)  
Liver disease 3 (5.5) 5 (4.4)  
Gastrointestinal disease 3 (5.5) 2 (1.8)  
Other malignancy 2 (3.6) 9 (8.0)  
Other 12 (21.8) 18 (15.9)  
Neutropenia (%) 8 (17.0) 7 (5.7) 0.094
Influenza (%) 17 (30.9) 47 (38.2) 0.442
COPD (%) 6 (10.9) 15 (12.2) 1.000
Positive culture (%) 28 (50.9)   
Positive microscopy (%) 4 (7.3)   
BALf GM (median [IQR]) 4.80 [2.73, 5.68]   
  1. IQR interquartile range, BALf GM bronchoalveolar lavage fluid galactomannan, COPD chronic obstructive pulmonary disease